Case Report
Readministration of Cancer Drugs in a Patient with Chemorefractory Metastatic Colorectal Cancer
Table 1
Treatment toxicities and performance status.
| | mFOLFOX6+Cetu | FOLFIRI | Trifluridine/tipiracil | S-1 | Panitumumab |
| Grade 1/2 | | | | | | Decreased WBCs | ○ | ○ | | | | Decreased neutrophils | | ○ | ○ | | | Anemia | ○ | ○ | ○ | ○ | ○ | Decreased platelets | ○ | | | ○ | | Fever | ○ | | ○ | ○ | ○ | Anorexia | ○ | | ○ | ○ | | Dry skin | ○ | | | | ○ | Peripheral neuropathy | ○ | ○ | | | | Insomnia | ○ | | | | | Paronychia | ○ | | | | ○ | Fatigue | | ○ | ○ | ○ | | Mucositis oral | | | | ○ | ○ | Diarrhea | | | | ○ | | Rash acneiform | | | | | ○ | Grade 3 | | | | | | Decreased neutrophils | ○ | | | | | PS | 1 | 1 | 2 | 1 | 1 |
|
|
Cetu: cetuximab; WBC: white blood cells.
|